StockWatch
·
Pharmaceuticals
Dividend29 May 2026, 02:05 pm

Ipca Labs Recommends ₹6 Dividend (600%) for FY26

AI Summary

Ipca Laboratories Ltd's board has recommended a dividend of ₹6 per share (600%) for the financial year ended March 31, 2026, subject to shareholder approval at the upcoming Annual General Meeting. The record date for dividend entitlement is fixed as August 7, 2026. Additionally, the board approved the re-appointment of Mr. Prashant Godha as Executive Director for another 5 years, effective August 16, 2026, also subject to shareholder approval. The Board Meeting started at 11.30 a.m. and concluded at 1.45 p.m.

Key Highlights

  • Ipca Labs recommends a dividend of ₹6 per share (600%) for FY26.
  • Record date for dividend entitlement is August 7, 2026, pending shareholder approval.
  • Prashant Godha re-appointed as Executive Director for 5 years from August 16, 2026.
  • Audited financial results for Q4 and FY26 approved with unmodified opinion.
  • Board meeting was held and concluded.